Skip to main content
. 2023 May 18:101795. Online ahead of print. doi: 10.1016/j.cpcardiol.2023.101795

Table 2.

Comparison of outcomes in HF patients with and without PSRFs

30-day outcomes Unadjusted outcomes Adjusted outcomes
With PSRFs Without PSRFs P value With PSRFs P value
N=175,348 N=130,607 N=175,348
All-cause readmissions 29,789 (16.9%) 20,886 (15.9%) <0.001 1.09 (1.06-1.11) <0.001
All-cause mortality 2,160 (1.2%) 1,695 (1.3%) 0.106 1.12 (1.04-1.20) 0.003
MACE 14,514 (8.2%) 9,883 (7.5%) <0.001 1.08 (1.04-1.12) <0.001
Myocardial infarction 2,647 (1.5%) 1,718 (1.3%) <0.001 1.08 (1.00-1.16) 0.036
Stroke 920 (0.5%) 650 (0.5%) 0.30 1.09 (0.97-1.23) 0.155
Cardiac readmissions 15,862 (9.0%) 11,195 (8.5%) <0.001 1.03 (0.99-1.06) 0.054
Non-cardiac readmissions 13,927 (7.9%) 9,691 (7.4%) <0.001 1.13 (1.10-1.17) <0.001
Heart failure readmissions 10,589 (6.0%) 7,023 (5.3%) <0.001 1.08 (1.04-1.12) <0.001

Data is represented as N (%), excepted adjusted outcomes. Adjusted outcomes are represented as odds ratio with confidence intervals.

Abbreviations: MACE, major adverse cardiovascular event; PSRF, psychosocial risk factor.

MACE includes composite of all-cause mortality, heart failure-readmissions, stroke and myocardial infarction.